Label: SOLUTIONKITS ENROFLOXACIN- enrofloxacin kit

  • Category: BULK INGREDIENT - ANIMAL DRUG
  • DEA Schedule: None
  • Marketing Status: Bulk Ingredient For Animal Drug Compounding

Drug Label Information

Updated January 3, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    SolutionKits™Enrofloxacin

    Enrofloxacin 125 mg/mL in SolutionKits™ Suspension Vehicle

    FOR VETERINARY COMPOUNDING ONLY

    Each kit includes:

    1 bottle containing Enrofloxacin Powder equivalent to 59.375g Enrofloxacin USP for Oral Suspension

    1 bottle containing 440 mL SolutionKits™ Suspension Vehicle provided as a suspending agent for compounding (Contains Artificial Sweet Flavoring)

    This kit contains 1 funnel

    A.P.I.

    Solutions

    Daphne, AL USA

    16.1 FL OZ (475 mL) as dispensed

  • PRINCIPAL DISPLAY PANEL

    box label

  • PRINCIPAL DISPLAY PANEL

    bottle label

  • PRINCIPAL DISPLAY PANEL

    suspension label

  • INGREDIENTS AND APPEARANCE
    SOLUTIONKITS  ENROFLOXACIN
    enrofloxacin kit
    Product Information
    Product TypeItem Code (Source)NDC:46144-605
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:46144-605-011 in 1 BOX
    Quantity of Parts
    Part #Package QuantityTotal Product Quantity
    Part 11 BOTTLE, PLASTIC 59.375 g
    Part 21 BOTTLE, PLASTIC 440 mL
    Part 1 of 2
    SOLUTIONKITS  ENROFLOXACIN
    enrofloxacin powder, for suspension
    Product Information
    Route of AdministrationNOT APPLICABLE
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ENROFLOXACIN (UNII: 3DX3XEK1BN) (ENROFLOXACIN - UNII:3DX3XEK1BN) ENROFLOXACIN1 g  in 1 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    159.375 g in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING
    Part 2 of 2
    ORAL SUSPENSION VEHICLE 
    suspension liquid
    Product Information
    Route of AdministrationNOT APPLICABLE
    Inactive Ingredients
    Ingredient NameStrength
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    AMMONIUM GLYCYRRHIZATE (UNII: 3VRD35U26C)  
    COCONUT OIL (UNII: Q9L0O73W7L)  
    BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)  
    POLYGLYCERYL-3 OLEATE (UNII: XRQ165498B)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1440 mL in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    BULK INGREDIENT FOR ANIMAL DRUG COMPOUNDING01/03/2022
    Labeler - API Solutions (831870824)